Medgate Deutschland GmbH
Medgate Deutschland GmbH, headquartered in Germany, is a leading player in the telemedicine industry, specialising in innovative healthcare solutions. Founded in 2000, the company has established a strong presence across Europe, particularly in Germany and Switzerland, by providing accessible and efficient medical services. Medgate is renowned for its unique telehealth platform, which offers remote consultations, health assessments, and personalised medical advice. This approach not only enhances patient convenience but also optimises healthcare delivery. With a commitment to quality and patient-centric care, Medgate has achieved significant milestones, including partnerships with various health insurers and recognition for its contributions to digital health. As a pioneer in telemedicine, Medgate Deutschland GmbH continues to shape the future of healthcare, making it a trusted name in the industry.
DitchCarbon Score
How does Medgate Deutschland GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medgate Deutschland GmbH's score of 24 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medgate Deutschland GmbH, headquartered in Germany, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Otto (GmbH & Co KG), which means that any emissions data or climate commitments may be inherited from this parent organisation. As a part of its climate strategy, Medgate Deutschland GmbH aligns with the sustainability initiatives of Otto (GmbH & Co KG). This includes participation in various climate-related frameworks, such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Otto at a level 2 relationship. However, specific reduction targets or achievements for Medgate Deutschland GmbH have not been disclosed. The company is committed to addressing climate change through these initiatives, although detailed metrics on emissions reductions or specific targets have not been provided. As such, Medgate Deutschland GmbH is positioned within a broader corporate family that prioritises sustainability, but lacks individual emissions data or distinct climate commitments at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 392,858,000 | 000,000,000 |
| Scope 2 | - | - |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medgate Deutschland GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
